Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Recombinant chimeric acetylcholine receptors and their derivatives recognized by CD4 T cells of myasthenic patients for the treatment of myasthenia gravis

Recombinant chimeric acetylcholine receptors and their derivatives recognized by CD4 T cells of myasthenic patients for the treatment of myasthenia gravis

US Patent 7777003 · Granted Aug 17, 2010

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Structural and functional characteristics of yeast-derived polysaccharide induci2024
Lactobacillus plant arum strain, polysaccharides derived from strain, and use th2023
Bifidobacterium bifidum strain and strain-derived polysaccharide2023